←Back to structures
MG592452.1__AUR85513.1__NVP1076O_08__00008
Bact-VirMG592452.1__AUR85513.1__NVP1076O_08__00008
Identity
- Accession:
- MG592452 ↗
- Kingdom:
- phage
Quality
75.3
mean pLDDT
Taxonomy
TaxID: 2070720
Cluster
Singleton — not in a non-trivial cluster
3D Structure
Domains
high = three domain segmentations agree, medium = two domain segmentations agree. Numbered high-first then medium, N→C within each tier.
D1
medium
residues 37-70
Domain cluster:
representative
CATH (21)
| Domain ID | Class ID | Classification | TM-score | Bits | E-value | Q cov | T cov |
|---|---|---|---|---|---|---|---|
| 4gi3C00 | 3.30.60.30 | Alpha Beta › 2-Layer Sandwich › Wheat Germ Agglutinin (Isolectin 2); domain 1 › | 0.68 | 54.0 | 4.82e-01 | 100.0% | 59.6% |
| 3r5dA02 | 3.30.60.70 | Alpha Beta › 2-Layer Sandwich › Wheat Germ Agglutinin (Isolectin 2); domain 1 › Trimeric LpxA-like enzymes | 0.67 | 51.0 | 5.05e-01 | 100.0% | 87.8% |
| 3sekC02 | 3.30.60.30 | Alpha Beta › 2-Layer Sandwich › Wheat Germ Agglutinin (Isolectin 2); domain 1 › | 0.65 | 48.0 | 4.28e-01 | 100.0% | 54.0% |
| 1pzxA02 | 2.20.28.50 | Mainly Beta › Single Sheet › Rubrerythrin, domain 2 › DegV, N-terminal domain, peripheral subdomain | 0.64 | 48.0 | 4.89e-01 | 100.0% | 100.0% |
| 1tbrR01 | 3.30.60.30 | Alpha Beta › 2-Layer Sandwich › Wheat Germ Agglutinin (Isolectin 2); domain 1 › | 0.64 | 47.0 | 4.49e-01 | 100.0% | 66.7% |
| 6kbrC00 | 3.30.60.30 | Alpha Beta › 2-Layer Sandwich › Wheat Germ Agglutinin (Isolectin 2); domain 1 › | 0.64 | 48.0 | 4.42e-01 | 100.0% | 63.6% |
| 4wz2C00 | 3.30.40.10 | Alpha Beta › 2-Layer Sandwich › Herpes Virus-1 › Zinc/RING finger domain, C3HC4 (zinc finger) | 0.64 | 50.0 | 4.14e-01 | 100.0% | 56.8% |
| 4mz0B05 | 3.30.70.250 | Alpha Beta › 2-Layer Sandwich › Alpha-Beta Plaits › Malonyl-CoA ACP transacylase, ACP-binding | 0.63 | 47.0 | 4.14e-01 | 100.0% | 91.0% |
| 5dinA00 | 3.30.40.10 | Alpha Beta › 2-Layer Sandwich › Herpes Virus-1 › Zinc/RING finger domain, C3HC4 (zinc finger) | 0.63 | 49.0 | 3.55e-01 | 100.0% | 38.3% |
| 2pbzA03 | 3.30.1490.20 | Alpha Beta › 2-Layer Sandwich › Dna Ligase; domain 1 › ATP-grasp fold, A domain | 0.63 | 43.0 | 4.26e-01 | 100.0% | 65.8% |
| 1uvgA01 | 3.30.60.30 | Alpha Beta › 2-Layer Sandwich › Wheat Germ Agglutinin (Isolectin 2); domain 1 › | 0.62 | 47.0 | 4.23e-01 | 100.0% | 60.3% |
| 6jzaA00 | 3.30.60.30 | Alpha Beta › 2-Layer Sandwich › Wheat Germ Agglutinin (Isolectin 2); domain 1 › | 0.62 | 45.0 | 3.79e-01 | 100.0% | 42.0% |
| 3wajA03 | 1.20.58.1650 | Mainly Alpha › Up-down Bundle › Methane Monooxygenase Hydroxylase; Chain G, domain 1 › | 0.61 | 47.0 | 3.51e-01 | 88.2% | 68.0% |
| 1rmdA01 | 3.30.40.10 | Alpha Beta › 2-Layer Sandwich › Herpes Virus-1 › Zinc/RING finger domain, C3HC4 (zinc finger) | 0.61 | 46.0 | 3.71e-01 | 100.0% | 54.7% |
| 3hh2D04 | 3.30.60.30 | Alpha Beta › 2-Layer Sandwich › Wheat Germ Agglutinin (Isolectin 2); domain 1 › | 0.61 | 44.0 | 3.86e-01 | 100.0% | 48.6% |
| 5d0iB00 | 3.30.40.10 | Alpha Beta › 2-Layer Sandwich › Herpes Virus-1 › Zinc/RING finger domain, C3HC4 (zinc finger) | 0.60 | 42.0 | 3.93e-01 | 85.3% | 68.6% |
| 6zepA01 | 3.40.630.10 | Alpha Beta › 3-Layer(aba) Sandwich › Aminopeptidase › Zn peptidases | 0.59 | 44.0 | 2.62e-01 | 97.1% | 10.5% |
| 2lxhC00 | 3.30.40.10 | Alpha Beta › 2-Layer Sandwich › Herpes Virus-1 › Zinc/RING finger domain, C3HC4 (zinc finger) | 0.57 | 40.0 | 3.62e-01 | 85.3% | 60.3% |
| 1w2lA00 | 1.10.760.10 | Mainly Alpha › Orthogonal Bundle › Cytochrome Bc1 Complex; Chain D, domain 2 › Cytochrome c-like domain | 0.56 | 42.0 | 3.16e-01 | 88.2% | 81.4% |
| 1wh2A01 | 3.30.1490.40 | Alpha Beta › 2-Layer Sandwich › Dna Ligase; domain 1 › GYF domain | 0.55 | 46.0 | 3.92e-01 | 100.0% | 68.9% |
| 3hxlA04 | 3.30.1370.220 | Alpha Beta › 2-Layer Sandwich › Ribosomal Protein S8; Chain: A, domain 1 › | 0.54 | 43.0 | 3.45e-01 | 100.0% | 58.2% |
ECOD (34)
| UID | F-ID | Classification | TM-score | Bits | E-value | Q cov | T cov |
|---|---|---|---|---|---|---|---|
| 3221968 | 386.1.1.0 ↗ | few secondary structure elements › beta-beta-alpha zinc fingers › beta-beta-alpha zinc fingers › beta-beta-alpha zinc fingers | 0.86 | 71.0 | 6.36e-01 | 100.0% | 66.0% |
| 3430198 | 386.1.1.0 ↗ | few secondary structure elements › beta-beta-alpha zinc fingers › beta-beta-alpha zinc fingers › beta-beta-alpha zinc fingers | 0.73 | 58.0 | 5.49e-01 | 100.0% | 75.6% |
| 3377039 | 386.1.1.137 ↗ | few secondary structure elements › beta-beta-alpha zinc fingers › beta-beta-alpha zinc fingers › beta-beta-alpha zinc fingers › zf-C2H2_STOP2_C | 0.72 | 57.0 | 5.55e-01 | 97.1% | 82.5% |
| 3354487 | 386.1.1.239 ↗ | few secondary structure elements › beta-beta-alpha zinc fingers › beta-beta-alpha zinc fingers › beta-beta-alpha zinc fingers › C2CH-3rd_BIRD-IDD, zf-C2H2_STOP2_3rd | 0.70 | 56.0 | 3.97e-01 | 100.0% | 30.0% |
| 3545298 | 379.1.1.1 ↗ | few secondary structure elements › Kazal-type serine protease inhibitors-like › Kazal-type serine protease inhibitors › Kazal-type serine protease inhibitors › Kazal_1 | 0.70 | 54.0 | 4.82e-01 | 100.0% | 59.3% |
| 3803242 | 386.1.1.120 ↗ | few secondary structure elements › beta-beta-alpha zinc fingers › beta-beta-alpha zinc fingers › beta-beta-alpha zinc fingers › C2CH-3rd_BIRD-IDD | 0.70 | 56.0 | 4.35e-01 | 100.0% | 42.4% |
| 4024576 | 376.1.1.61 ↗ | few secondary structure elements › RING/U-box-like › RING/U-box-like › RING/U-box › Rtf2 | 0.69 | 55.0 | 4.43e-01 | 94.1% | 70.0% |
| 3575790 | 379.1.1.3 ↗ | few secondary structure elements › Kazal-type serine protease inhibitors-like › Kazal-type serine protease inhibitors › Kazal-type serine protease inhibitors › Kazal_2 | 0.69 | 54.0 | 4.60e-01 | 100.0% | 51.7% |
| 153859 | 379.1.1.0 ↗ | few secondary structure elements › Kazal-type serine protease inhibitors-like › Kazal-type serine protease inhibitors › Kazal-type serine protease inhibitors | 0.68 | 54.0 | 4.82e-01 | 100.0% | 59.6% |
| 3461223 | 376.1.1.0 ↗ | few secondary structure elements › RING/U-box-like › RING/U-box-like › RING/U-box | 0.68 | 56.0 | 4.77e-01 | 100.0% | 61.7% |
| 3659589 | 376.1.1.1 ↗ | few secondary structure elements › RING/U-box-like › RING/U-box-like › RING/U-box › zf-C3HC4 | 0.68 | 55.0 | 4.63e-01 | 100.0% | 70.8% |
| 4018018 | 376.1.1.21 ↗ | few secondary structure elements › RING/U-box-like › RING/U-box-like › RING/U-box › zf-RING_2 | 0.68 | 52.0 | 3.90e-01 | 97.1% | 54.4% |
| 3625316 | 376.1.1.27 ↗ | few secondary structure elements › RING/U-box-like › RING/U-box-like › RING/U-box › zf-RING_5 | 0.68 | 51.0 | 4.57e-01 | 91.2% | 65.5% |
| 4961835 | 377.9.1.0 ↗ | few secondary structure elements › Glucocorticoid receptor-like › HIT/MYND zinc finger-like › HIT/MYND zinc finger-like | 0.67 | 53.0 | 4.35e-01 | 97.1% | 52.1% |
| 3320420 | 376.1.1.1 ↗ | few secondary structure elements › RING/U-box-like › RING/U-box-like › RING/U-box › zf-C3HC4 | 0.67 | 52.0 | 4.27e-01 | 100.0% | 68.0% |
| None | — | 0.67 | 52.0 | 4.30e-01 | 100.0% | 64.0% | |
| 3903607 | 379.1.1.0 ↗ | few secondary structure elements › Kazal-type serine protease inhibitors-like › Kazal-type serine protease inhibitors › Kazal-type serine protease inhibitors | 0.66 | 48.0 | 4.23e-01 | 100.0% | 50.0% |
| 3333934 | 376.1.1.0 ↗ | few secondary structure elements › RING/U-box-like › RING/U-box-like › RING/U-box | 0.66 | 50.0 | 4.02e-01 | 100.0% | 49.4% |
| 3782574 | 376.1.1.61 ↗ | few secondary structure elements › RING/U-box-like › RING/U-box-like › RING/U-box › Rtf2 | 0.65 | 51.0 | 4.29e-01 | 100.0% | 67.1% |
| 4027862 | 376.1.1.17 ↗ | few secondary structure elements › RING/U-box-like › RING/U-box-like › RING/U-box › zf-rbx1 | 0.65 | 50.0 | 4.11e-01 | 97.1% | 50.7% |
| 3532400 | 376.1.1.22 ↗ | few secondary structure elements › RING/U-box-like › RING/U-box-like › RING/U-box › zf-C3HC4_3 | 0.65 | 49.0 | 4.30e-01 | 100.0% | 69.2% |
| 3709844 | 376.1.1.21 ↗ | few secondary structure elements › RING/U-box-like › RING/U-box-like › RING/U-box › zf-RING_2 | 0.65 | 54.0 | 4.50e-01 | 100.0% | 69.2% |
| 3415617 | 379.1.1.1 ↗ | few secondary structure elements › Kazal-type serine protease inhibitors-like › Kazal-type serine protease inhibitors › Kazal-type serine protease inhibitors › Kazal_1 | 0.65 | 52.0 | 4.77e-01 | 100.0% | 68.0% |
| 3235687 | 375.1.1.0 ↗ | few secondary structure elements › Rubredoxin-like › Rubredoxin-related › Rubredoxin-related | 0.65 | 53.0 | 4.45e-01 | 100.0% | 100.0% |
| 4277033 | 379.1.1.1 ↗ | few secondary structure elements › Kazal-type serine protease inhibitors-like › Kazal-type serine protease inhibitors › Kazal-type serine protease inhibitors › Kazal_1 | 0.64 | 49.0 | 4.47e-01 | 100.0% | 61.8% |
| 8244 | 379.1.1.1 ↗ | few secondary structure elements › Kazal-type serine protease inhibitors-like › Kazal-type serine protease inhibitors › Kazal-type serine protease inhibitors › Kazal_1 | 0.64 | 48.0 | 4.30e-01 | 100.0% | 58.3% |
| 4180025 | 376.1.1.21 ↗ | few secondary structure elements › RING/U-box-like › RING/U-box-like › RING/U-box › zf-RING_2 | 0.63 | 47.0 | 3.57e-01 | 100.0% | 43.6% |
| 3324521 | 376.1.1.23 ↗ | few secondary structure elements › RING/U-box-like › RING/U-box-like › RING/U-box › zf-C3HC4_2 | 0.63 | 48.0 | 4.19e-01 | 100.0% | 64.6% |
| 4488994 | 376.1.1.1 ↗ | few secondary structure elements › RING/U-box-like › RING/U-box-like › RING/U-box › zf-C3HC4 | 0.62 | 45.0 | 4.05e-01 | 100.0% | 75.4% |
| 3400250 | 379.1.1.3 ↗ | few secondary structure elements › Kazal-type serine protease inhibitors-like › Kazal-type serine protease inhibitors › Kazal-type serine protease inhibitors › Kazal_2 | 0.61 | 53.0 | 4.74e-01 | 100.0% | 68.0% |
| 3941506 | 2002.1.1.16 ↗ | a/b barrels › TIM beta/alpha-barrel › TIM barrels › TIM barrels › Bac_luciferase | 0.61 | 44.0 | 2.61e-01 | 88.2% | 35.8% |
| 3865539 | 376.1.1.29 ↗ | few secondary structure elements › RING/U-box-like › RING/U-box-like › RING/U-box › zf-C3HC4_4 | 0.60 | 44.0 | 3.60e-01 | 100.0% | 55.6% |
| 3303628 | 822.1.1.3 ↗ | a+b two layers › GYF/BRK domain-like › GYF domain › GYF domain › GYF_ATXR3 | 0.60 | 49.0 | 4.49e-01 | 100.0% | 80.0% |
| 3718286 | 376.1.1.8 ↗ | few secondary structure elements › RING/U-box-like › RING/U-box-like › RING/U-box › U-box | 0.55 | 39.0 | 3.50e-01 | 100.0% | 71.4% |